Id4 promotes senescence and sensitivity to doxorubicin-induced apoptosis in DU145 prostate cancer cells

Anticancer Research

Volumn 33, Issue 10, 2013, Pages 4271-4278

  Carey, Jason P ^a   Knowell, Ashley Evans ^a   Chinaranagari, Swathi ^a   Chaudhary, Jaideep ^a  

^a CLARK ATLANTA UNIVERSITY   (United States)

Author keywords

Apoptosis; DU145; E2F1; Id4; Senescence

Indexed keywords

ANDROGEN RECEPTOR; BETA GALACTOSIDASE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DOXORUBICIN; IMMUNOGLOBULIN; INHIBITOR OF DIFFERENTIATION PROTEIN; PROTEIN P16; PROTEIN P21; PROTEIN P27; TRANSCRIPTION FACTOR E2F1; UVOMORULIN; VIMENTIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL AGING; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; DU145; E2F1; ID4; SENESCENCE;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CADHERINS; CELL AGING; CELL LINE, TUMOR; CELL SHAPE; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEINS; MALE; PROSTATIC NEOPLASMS; TUMOR SUPPRESSOR PROTEINS; VIMENTIN;

EID: 84891360709     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Murre C, Bain G, van Dijk MA, Engel I, Furnari BA, Massari ME, Matthews JR, Quong MW, Rivera RR and Stuiver MH: Structure and function of helix-loop-helix proteins. Biochim Biophys Acta 1218: 129-135, 1994.
2. Yokota Y and Mori S: Role of Id family proteins in growth control. J Cell Physiol 190: 21-28, 2002.
3. Umetani N, Mori T, Koyanagi K, Shinozaki M, Kim J, Giuliano AE and Hoon DSB: Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer. Oncogene 24: 4721-4727, 2005.
4. Sharma P, Chinaranagari S, Patel D, Carey J and Chaudhary J: Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer. Cancer medicine 1: 176-186, 2012.
5. Carey JP, Asirvatham AJ, Galm O, Ghogomu TA and Chaudhary J: Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer. BMC Cancer 9: 173, 2009.
6. Park C, Lee I and Kang WK: E2F-1 is a critical modulator of cellular senescence in human cancer. Int J Mol Med 17: 715-720, 2006.
7. Nevins JR: The Rb/E2F pathway and cancer. Human molecular genetics 10: 699-703, 2001.
8. Lanigan F, Geraghty JG and Bracken AP: Transcriptional regulation of cellular senescence. Oncogene 30: 2901-2911, 2011.
9. Tamimi Y, Bringuier PP, Smit F, van Bokhoven A, Debruyne FM and Schalken JA: p16 mutations/deletions are not frequent events in prostate cancer. British journal of cancer 74: 120-122, 1996.
10. Bookstein R, Rio P, Madreperla SA, Hong F, Allred C, Grizzle WE and Lee WH: Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci USA 87: 7762-7766, 1990.
11. Asirvatham AJ, Schmidt MA and Chaudhary J: Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells. The Prostate 66: 921-935, 2006.
12. Carey JPW, Asirvatham AJ, Galm O, Ghogomu TA and Chaudhary J: Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer. BMC Cancer 9: 173-173, 2009.
13. Katz ML, Robison WG, Herrmann RK, Groome AB and Bieri JG: Lipofuscin accumulation resulting from senescence and vitamin E deficiency: spectral properties and tissue distribution. Mech Ageing Dev 25: 149-159, 1984.
14. Rodier F and Campisi J: Four faces of cellular senescence. J Cell Biol 192: 547-556, 2011.
15. Jia L, Li H and Sun Y: Induction of p21-dependent senescence by an NAE inhibitor, MLN4924, as a mechanism of growth suppression. Neoplasia 13: 561-569, 2011.
16. Majumder PK, Grisanzio C, O'Connell F, Barry M, Brito JM, Xu Q, Guney I, Berger R, Herman P, Bikoff R, Fedele G, Baek WK, Wang S, Ellwood-Yen K, Wu H, Sawyers CL, Signoretti S, Hahn WC, Loda M and Sellers WR: A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression. Cancer Cell 14: 146-155, 2008.
17. Waf1/Cip1. Oncogene 18: 5381-5392, 1999.
18. Kitaura H, Shinshi M, Uchikoshi Y, Ono T, Iguchi-Ariga SM, and Ariga H: Reciprocal regulation via protein-protein interaction between c-Myc and p21(cip1/waf1/sdi1) in DNA replication and transcription. J Biol Chem 275: 10477-10483, 2000.
19. Ewald JA, Desotelle JA, Wilding G and Jarrard DF: Therapy-induced senescence in cancer. Journal of the National Cancer Institute 102: 1536-1546, 2010.
20. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O et al: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363-9367, 1995.
21. Ewald JA, Peters N, Desotelle JA, Hoffmann FM and Jarrard DF: A high-throughput method to identify novel senescence-inducing compounds. Journal of biomolecular screening 14: 853-858, 2009.
22. Nishio K, Inoue A, Qiao S, Kondo H and Mimura A: Senescence and cytoskeleton: overproduction of vimentin induces senescent-like morphology in human fibroblasts. Histochem Cell Biol 116: 321-327, 2001.
23. Elston MS, Gill AJ, Conaglen JV, Clarkson A, Cook RJ, Little NS, Robinson BG, Clifton-Bligh RJ and McDonald KL: Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas. J Clin Endocrinol Metab 94: 1436-1442, 2009.
24. Vergel M, Marin JJ, Estevez P and Carnero A: Cellular senescence as a target in cancer control. Journal of aging research 2011: 1-12, 2010.
25. Sliwinska MA, Mosieniak G, Wolanin K, Babik A, Piwocka K, Magalska A, Szczepanowska J, Fronk J and Sikora E: Induction of senescence with doxorubicin leads to increased genomic instability of HCT116 cells. Mech Ageing Dev 130: 24-32, 2009.
26. Ling MT, Wang X, Ouyang XS, Xu K, Tsao SW and Wong YC: Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells. Oncogene 22: 4498-4508, 2003.
27. Sharma P, Patel D and Chaudhary J: Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B. Cancer medicine 1: 187-197, 2012.
28. Pantoja C and Serrano M: Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras. Oncogene 18: 4974-4982, 1999.
29. Sun B, Wingate H, Swisher SG, Keyomarsi K and Hunt KK: Absence of pRb facilitates E2F1-induced apoptosis in breast cancer cells. Cell Cycle 9: 1122-1130, 2010.
30. Dimri GP and Campisi J: Molecular and cell biology of replicative senescence. Cold Spring Harb Symp Quant Biol 59: 67-73, 1994.